ELV — Elevance Health Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapContrarian

Annual cashflow statement for Elevance Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	PRESS
Standards:	USG	USG	USG	USG	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	6,095	6,019	5,991	5,971	5,661
Depreciation
Deferred Taxes
Non-Cash Items	349	271	735	93	763
Unusual Items
Other Non-Cash Items
Changes in Working Capital	292	510	192	-1,341	-3,680
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Taxes Payable
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Gains / Losses on Investment Securities
Change in Reinsurance Receivable
Change in Unearned Premiums
Cash from Operating Activities	8,364	8,399	8,061	5,742	4,290
Capital Expenditures	-1,087	-1,152	-1,296	-1,256	-1,116
Purchase of Fixed Assets
Other Investing Cash Flow Items	-8,551	-3,408	-4,276	-3,911	-228
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-9,638	-4,560	-5,572	-5,167	-1,344
Financing Cash Flow Items	505	250	-169	-182	1,767
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	423	-1,318	-3,349	1,193	-1,738
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-861	2,507	-861	1,762	1,203